Name: Human Anti-CD19 x Anti-CD47 Bispecific Antibody (IgG-IgG)
SKU: BSIG-H217
Rating: 5 (1 reviews)

Anti-CD19 x Anti-CD47 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD19 and anti-CD47 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget macrophages to tumor cells. It is designed for the research of B cell lymphoma; Follicular lymphoma; Burkitt lymphoma; Leukemia therapy.

Datasheet INQUIRY

Specifications

Targets

CD19 & CD47

Type

IgG-IgG

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

B cell lymphoma; Follicular lymphoma; Burkitt lymphomaLeukemia

Host Animal 1

Human

Host Animal 2

Human

Targets

Target 1

CD19

Gene ID

930

UniProt ID

P15391

Alternative Names

CD19; CD19 molecule; Cluster of differentiation 19; B4; CVID3; B-lymphocyte antigen CD19; differentiation antigen CD19; T-cell surface antigen Leu-12; B-lymphocyte surface antigen B4

Target 2

CD47

Gene ID

961

UniProt ID

Q08722

Alternative Names

CD47; CD47 molecule; IAP; OA3; MER6; leukocyte surface antigen CD47; CD47 glycoprotein; Rh-related antigen; integrin associated protein; integrin-associated protein; integrin-associated signal transducer; antigenic surface determinant protein OA3; antigen identified by monoclonal antibody 1D8; CD47 antigen (Rh-related antigen, integrin-associated signal transducer)

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Human Anti-CD19 x Anti-CD47 Bispecific Antibody (IgG-IgG) (BSIG-H217). Click the button below to contact us or submit your feedback about this product.

Human Anti-CD19 x Anti-CD47 Bispecific Antibody (IgG-IgG) (CAT#: BSIG-H217)

Specifications

Targets

Customer Reviews and Q&As